Tsuruha Holdings Inc.
Financial Summary for the Third Quarter of the Fiscal Year Ending February 2026 (Completion of Interim Review by Audit Firm)
For the third quarter of the fiscal year ending February 2026, net sales were JPY 833,383 million, operating income JPY 40,595 million, and net income attributable to owners of parent JPY 26,976 million. Completed business integration with Welcia Holdings, increasing the number of stores to 2,690.
Key Figures
- Net Sales: JPY 833,383 million (Third Quarter of Fiscal Year Ending February 2026)
- Operating Income: JPY 40,595 million (Third Quarter of Fiscal Year Ending February 2026)
- Net Income Attributable to Owners of Parent: JPY 26,976 million (Third Quarter of Fiscal Year Ending February 2026)
AI要約
Performance Overview
For the third quarter of the fiscal year ending February 2026 (March 1, 2025 to November 30, 2025), net sales were JPY 833,383 million, operating income JPY 40,595 million, ordinary income JPY 40,733 million, and net income attributable to owners of parent JPY 26,976 million. Year-over-year comparisons were not conducted due to the change in the fiscal period. The economic environment experienced a moderate recovery influenced by U.S. trade policies, and although the drugstore industry faced intensified competition and stronger price sensitivity, performance remained broadly favorable.
Business Integration and Store Expansion
On December 1, 2025, the company completed its business integration with Welcia Holdings Co., Ltd., forming Japan’s largest drugstore alliance. The number of directly operated stores reached 2,690 (78 openings, 46 closures), with efforts underway to strengthen pharmacy services and private brand products. Total assets amounted to JPY 664.451 billion, total liabilities were JPY 339.252 billion, and total net assets reached JPY 325.198 billion, resulting in an equity ratio of 45.0%, representing a decrease of 3.2 percentage points.
